Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000216509 | SCV000269339 | benign | not specified | 2014-10-29 | criteria provided, single submitter | clinical testing | p.Asn446Asn in exon 9 of MYOM1: This variant is not expected to have clinical si gnificance because it has been identified in 31% (1167/3758) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu /EVS/; dbSNP rs2230167). |
Ambry Genetics | RCV000216509 | SCV000739813 | likely benign | not specified | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000838124 | SCV000979988 | benign | not provided | 2018-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001520122 | SCV001729144 | benign | Hypertrophic cardiomyopathy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000838124 | SCV005248189 | benign | not provided | criteria provided, single submitter | not provided |